King Bud
An obscure cannabis strain name attached to several unrelated genetics, with little verifiable breeder documentation or lab data.
King Bud is one of those names that gets slapped on multiple unrelated plants depending on who's selling. There is no single authoritative breeder release, no consistent chemotype data in public lab databases, and most of what you'll read online is dispensary copy or seedbank marketing. Treat any specific THC percentage, terpene profile, or lineage claim about 'King Bud' with skepticism unless the seller can show you a COA for that exact batch.
Overview
"King Bud" is a strain name that appears across seedbank listings, dispensary menus, and grower forums, but it does not trace back to a single authenticated breeder release. Different vendors describe it as an indica, a hybrid, or even a generic "top-shelf" designation rather than a specific cultivar. Disputed
Unlike well-documented cultivars such as OG Kush or Chemdog, King Bud has no widely-cited origin story, no canonical phenotype, and no consistent chemotype across the samples sold under the name. In practice, two products labeled "King Bud" from different sources are unlikely to be the same plant. Weak / limited
Chemistry: cannabinoids and terpenes
There is no published peer-reviewed chemotyping of a cultivar specifically named "King Bud." Public lab data aggregators such as Leafly and PSI Labs do not surface a consistent profile for the name. No data
Vendor claims typically place THC around 18–24% and CBD below 1%, which is unremarkable and matches the broad distribution of modern commercial flower in legal U.S. markets. A 2021 analysis of more than 90,000 commercial flower samples found mean THC around 20% with CBD typically under 1% [1], so vendor numbers for King Bud sit comfortably within that average and tell you essentially nothing distinctive. Strong evidence
Terpene claims for King Bud vary wildly between listings — myrcene, caryophyllene, and limonene have all been named as "dominant" by different sellers. Without a batch-specific certificate of analysis (COA), assume nothing. No data
Reported effects
No clinical trials have studied King Bud, and no controlled human research exists on this strain by name. No data All reported effects come from dispensary reviews and forum posts, which are subject to placebo, expectancy, and the well-documented unreliability of strain naming itself.
A 2022 study by Smith et al. genotyped commercial cannabis and found that samples sharing a strain name were frequently not genetically related, undermining the assumption that a strain name predicts a consistent experience [2]. The broader "indica vs. sativa predicts effects" framework is also poorly supported by chemistry [3]. Strong evidence
If a vendor tells you King Bud will reliably make you sleepy, euphoric, or pain-free, that is folklore plus marketing, not evidence. Your best predictor of effect remains the actual cannabinoid and terpene profile on the COA, your dose, your tolerance, and your setting.
Lineage
Lineage for King Bud is genuinely unclear. Disputed
- Some seedbank listings describe it as an indica-dominant hybrid of unspecified parentage.
- Others have used "King Bud" or "Kingsbud" as a generic premium-grade label rather than a cultivar name.
- No major breeder (Sensi Seeds, DNA Genetics, Humboldt Seed Co., etc.) lists a flagship release by this name with documented parentage.
Without a breeder of record or published genetic data (for example, via the Phylos Galaxy or Medicinal Genomics' StrainSEEK), claims about King Bud's ancestry should be treated as unverified. No data
Cultivation basics
Because there is no canonical King Bud cut circulating with documented grower notes, cultivation guidance online is largely generic. Vendor descriptions usually cite an 8–10 week indoor flowering window, which is unremarkable for most modern photoperiod hybrids. Weak / limited
If you obtain seeds or a clone labeled King Bud:
- Expect phenotype variability from seed, especially given the unclear lineage.
- Treat the plant as an unknown until you've run it: log internode spacing, stretch, nutrient tolerance, and finishing time yourself.
- Send a sample to a lab for cannabinoid and terpene analysis if you want to know what you actually have.
General best practices for indoor flower — VPD management, light intensity around 800–1000 µmol/m²/s PPFD in flower for well-fed canopies, and proper post-harvest cure — will matter far more to your result than the name on the seed packet [4].
Marketing vs. reality
King Bud is a useful case study in cannabis naming problems:
- The name is not protected. Cannabis strain names are not trademarked or regulated in any meaningful way across most markets, and anyone can label flower "King Bud" [2]. Strong evidence
- "King," "royal," and "OG" are marketing prefixes, not chemistry. They signal premium pricing intent, not a verified profile.
- THC percentage is a poor predictor of subjective effect. A 2020 study found that blood THC concentration after smoking flower of varying potency did not track linearly with self-reported intoxication [5]. Buying "King Bud" because it's labeled 24% THC is buying a number, not an experience. Strong evidence
If you like a specific batch sold as King Bud, great — buy more of that batch from that vendor while it lasts. Do not assume the next jar with the same sticker will deliver the same thing.
Sources
- Peer-reviewed Smith, C. J., Vergara, D., Keegan, B., & Jikomes, N. (2022). The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE, 17(5), e0267498.
- Peer-reviewed Schwabe, A. L., & McGlaughlin, M. E. (2019). Genetic tools weed out misconceptions of strain reliability in Cannabis sativa: implications for a budding industry. Journal of Cannabis Research, 1(1), 3.
- Peer-reviewed Piomelli, D., & Russo, E. B. (2016). The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD. Cannabis and Cannabinoid Research, 1(1), 44–46.
- Book Cervantes, J. (2015). The Cannabis Encyclopedia: The Definitive Guide to Cultivation & Consumption of Medical Marijuana. Van Patten Publishing.
- Peer-reviewed Spindle, T. R., Cone, E. J., Schlienz, N. J., Mitchell, J. M., Bigelow, G. E., Flegel, R., Hayes, E., & Vandrey, R. (2020). Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid. Journal of Analytical Toxicology, 44(8), 838–848.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- OG Kush — The hazy-origin California strain that became the genetic backbone of modern American cann...